Back to Journals » Journal of Experimental Pharmacology » Volume 14

Original Research

Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2/D3 Selective Receptor Antagonist for the Management of Gastroparesis

       
Total article views   HTML views PDF downloads Totals
6,603 Dovepress* 6,318+ 371 6,689
PubMed Central* 285 71 356
Totals 6,603 442 7,045
*Since 9 February 2022
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed and Google Scholar